Precis: Approximately one-quarter of lacrimal gland masses present with imaging findings not consistent with standard teaching for benign vs. malignant; it is prudent to do gross total resection in such cases if eye-sparing surgery is possible. Background: Epithelial lacrimal gland tumors are rare. The initial surgical decision to do an incisional biopsy vs. gross total resection depends largely on the radiologic characteristics of the lacrimal gland mass. Occasionally, the reported radiologic features attributed to benign vs. malignant lacrimal gland tumors do not hold. In this report, we will focus on these atypical presentations to help the orbital surgeon with better surgical planning. Methods: Epithelial lacrimal gland tumors diagnosed in 101 consecutive patients (59 adenoid cystic carcinomas, 24 other carcinomas, and 18 pleomorphic adenomas) and treated by the primary author were included. The clinical and radiologic records were retrospectively reviewed. The clinical parameters analyzed included age, gender, histologic type, and surgical treatment. The radiologic data analyzed included radiologic characteristics of the lacrimal gland mass on the initial magnetic resonance imaging (MRI) and/or computed tomography (CT) at presentation. Cases that did not follow the “standard” imaging characteristics of carcinoma or pleomorphic adenoma were further analyzed. Results: Overall, two possible atypical radiologic patterns were identified: (1) 11 of 59 (19%) cases of adenoid cystic carcinoma and 5 of 24 (21%) cases of other carcinomas were identified where the lesion was round and well-circumscribed, lacked a posterior extension or other aggressive features, and could not be distinguished from pleomorphic adenoma but after surgical resection were found to be adenoid cystic carcinoma or other types of lacrimal gland carcinoma; (2) 5 of 18 (28%) cases of pleomorphic adenoma presented with large multilobular masses and could not be distinguished from a carcinoma but in fact were found to be of benign nature on histologic evaluation. Conclusions: Our findings suggest some overlap in radiologic features between pleomorphic adenomas and lacrimal gland carcinomas. Given the risk of multifocal benign or malignant recurrence of pleomorphic adenomas if excised incompletely, it seems prudent to err on the side of gross total resection for most well-circumscribed lesions of the lacrimal gland that lack aggressive radiologic features. Some of these well-circumscribed lesions will end up being adenoid cystic carcinoma or other types of lacrimal gland carcinomas upon pathologic evaluation of the surgical specimen and may require additional treatments.
28 October 2025 in Radiologic Clinics of North America
Orbital imaging has undergone a significant transformation over the past few decades, evolving from basic radiographic techniques to sophisticated cross-sectional imaging modalities. Historically, conventional radiography was limited to visualizing only the bony structures of the orbit or radiodense foreign bodies, making it inadequate for detecting soft tissue pathology. Advances in imaging over the last several decades—first with computed tomography (CT) in the 1970s and later with magnetic resonance imaging (MRI) in the 1980s—have revolutionized orbital diagnostics by enabling detailed visualization of both osseous and soft tissue structures. Magnetic resonance imaging (MRI) has emerged as the preferred modality for evaluating orbital tumors and other soft tissue lesions. Its superior soft tissue resolution, multiplanar imaging capability, and ability to characterize lesion morphology and extent make it crucial in clinical practice. MRI is especially valuable in differentiating benign from malignant lesions, evaluating involvement of critical structures such as the globe, optic nerve, extraocular muscles, and vascular components, and assessing disease at the orbital apex or with suspected intracranial extension. Advanced MRI techniques, including diffusion-weighted imaging (DWI) and dynamic contrast-enhanced (DCE) MRI, further enhance diagnostic accuracy. In pediatric populations, MRI holds particular importance due to its lack of ionizing radiation and its effectiveness. In contrast, while CT offers superior resolution of bony anatomy and is useful for detecting calcifications and fractures, it is somewhat limited in soft tissue differentiation and involves exposure to ionizing radiation. While CT examination can be tailored to evaluate bone or soft tissues, orbital CT is typically reserved for cases requiring detailed osseous assessment, acute trauma settings, or for patients who cannot undergo an MRI. MRI creates high-resolution images by detecting signals emitted by hydrogen nuclei when exposed to a strong magnetic field and radiofrequency pulses. Differences in signal based on tissue composition and water content are captured and converted into high-resolution images. Interpreting orbital lesions requires standardized terminology.
1 April 2026 in Radiologic Clinics of North America
While most ophthalmologists and medical oncologists are aware of the excessive tearing and canalicular and lacrimal duct blockage associated with docetaxel, there is lack of deeper understanding of the appropriate management of this side effect and what clinical settings justify surgical intervention as opposed to conservative management. In this review, we summarize the findings in the seminal original research studies that document the association between the frequency of administration of docetaxel and treatment duration and the frequency of excessive tearing as a subjective symptom versus canalicular and lacrimal duct blockage as anatomic findings seen during probing and irrigation. Based on the published literature to date, we note that excessive tearing is a common and important side effect of docetaxel and can be seen in breast cancer patients who are receiving docetaxel either weekly or every three weeks in metastatic or adjuvant settings. However, the anatomic findings of canalicular and lacrimal duct stenosis are almost exclusively seen in patients receiving weekly docetaxel or in patients with metastatic breast cancer who are treated with docetaxel for prolonged periods. Lacrimal duct blockage is much less commonly reported in patients with early breast cancer who are receiving docetaxel every three weeks for short durations and, to our knowledge to date, have not been reported in the literature in breast cancer patients receiving docetaxel in the adjuvant setting.